What is ONCO's P/E ratio?

ONCONETIX INC (ONCO) currently trades at a P/E ratio of 0.51.

ONCONETIX INC reports a Return on Equity (ROE) of -82.59%.

What is ONCO's dividend yield?

ONCONETIX INC offers a dividend yield of 0.00%.

What is ONCO's Quality Score?

Our AI rates ONCO's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ONCO?

Our AI Timing Score for ONCO is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ONCO belong to?

ONCONETIX INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

ONCO (NASDAQ) Stock Analysis | ONCONETIX INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

ONCO AI Analysis Summary

Our AI summary for ONCO: ONCONETIX INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.51, ROE of -82.59%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ONCO

ONCONETIX INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 91

USD 0.83

0.04 (5.12%) Day Change

Watchlist Portfolio Compare Chart

0.51

P/E

0.02

D/E

-82.6%

ROE

-65.4%

ROA

0.00%

Div Yield

-0.02

PEG

ONCONETIX INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.83 Price 0.04 (5.12%) Day Change	NEWS SCORE: 91

ONCO, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	91
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.83
PBV / Sector	0.25 / 5.20 GREAT
Earning Per Share	-2.76

PE / Sector	0.51 / 19.97 GREAT
PEG or PE/Growth / Sector	-0.02 / 1.22
Average 1M Daily Value	0.40 M GREAT
Average 1W Daily Value	0.18 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

47%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-1,319.55 / 98.71
NPM Average (%) / Sector	-17,338.05 / -1,721.76
NPM Change Average (%) / Sector	N/A / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-65.41 / 27.02
ROA Average (%) / Sector	-84.74 / -368.17
ROA Change Average (%) / Sector	78.56 / 5,404.12 GREAT
ROE (%) / Sector	-82.59 / 3.47
ROE Average (%) / Sector	-34.89 / 6.51
ROE Change Average (%) / Sector	-374.54 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 08:00:16
Symbol	ONCO
Name	ONCONETIX INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	3.69 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	2.90 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 201 East Fifth Street, Cincinnati, OH, United States, 45202

Phone: 513 620 4101

Website: https://www.onconetix.com

Sector: Healthcare >> Biotechnology

Description: Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.